- Home
- BEEP vs FBRX Comparison
BEEP vs FBRX Comparison
Compare BEEP & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEP
- FBRX
- Stock Information
- Founded
- BEEP 2015
- FBRX N/A
- Country
- BEEP United States
- FBRX United States
- Employees
- BEEP N/A
- FBRX N/A
- Industry
- BEEP Blank Checks
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- BEEP Finance
- FBRX Health Care
- Exchange
- BEEP Nasdaq
- FBRX Nasdaq
- Market Cap
- BEEP 150.7M
- FBRX 154.5M
- IPO Year
- BEEP N/A
- FBRX N/A
- Fundamental
- Price
- BEEP $4.05
- FBRX $11.43
- Analyst Decision
- BEEP Strong Buy
- FBRX Strong Buy
- Analyst Count
- BEEP 2
- FBRX 3
- Target Price
- BEEP $6.75
- FBRX $68.00
- AVG Volume (30 Days)
- BEEP 29.4K
- FBRX 59.5K
- Earning Date
- BEEP 08-12-2025
- FBRX 08-14-2025
- Dividend Yield
- BEEP N/A
- FBRX N/A
- EPS Growth
- BEEP N/A
- FBRX N/A
- EPS
- BEEP N/A
- FBRX N/A
- Revenue
- BEEP $36,142,000.00
- FBRX N/A
- Revenue This Year
- BEEP $1.29
- FBRX N/A
- Revenue Next Year
- BEEP $5.56
- FBRX N/A
- P/E Ratio
- BEEP N/A
- FBRX N/A
- Revenue Growth
- BEEP 6.15
- FBRX N/A
- 52 Week Low
- BEEP $2.65
- FBRX $4.11
- 52 Week High
- BEEP $4.86
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- BEEP 59.32
- FBRX 54.64
- Support Level
- BEEP $3.45
- FBRX $9.91
- Resistance Level
- BEEP $3.93
- FBRX $13.63
- Average True Range (ATR)
- BEEP 0.19
- FBRX 0.92
- MACD
- BEEP 0.04
- FBRX 0.14
- Stochastic Oscillator
- BEEP 100.00
- FBRX 51.43
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).